On the surface, Martia was like so many of my clients - in her late 60s, she had sciatic pain in her left leg, and wanted to combat her rounded shoulders and 'tech neck'.
GSK has claimed approval in the EU for Exdensur, a long-acting respiratory drug that is considered one of its top growth prospects. The approval of Exdensur (depemokimab) for severe asthma and chronic ...
JACKSON , MS, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- As the warmer weather of spring approaches, so does ...
Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...
Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.
This chronic lung condition causes your airways to become permanently widened and scarred. Learn how to spot and treat this ...
For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not ...
"Today's approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment," said Iilun Murph ...
Phase 3 LIBERTY-AIMS results showed dupilumab reduced nasal polyp size and sinus symptoms in adults and children with allergic fungal rhinosinusitis.
Asthma biologic use was not associated with an increase in respiratory infection risk, according to results from the 2026 ...
Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...
Kyowa Kirin on Tuesday said it is discontinuing all ongoing trials of its experimental drug to treat skin conditions after the company concluded that the potential risks may outweigh the benefits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results